Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment

Ranibizumab for Diabetic Macular Edema

(2012) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review

(2011) Ingrid Zechmeister-Koss et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells

(2011) H. L. Deissler et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Effect of OCT volume scan density on thickness measurements in diabetic macular edema

(2011) M G Nittala et al.   EYE

Association between photoreceptor integrity and visual outcome in diabetic macular edema

(2011) Hyun Jin Shin et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Optical Coherence Tomographic Patterns in Diabetic Macula Edema Can Predict the Effects of Intravitreal Bevacizumab Injection as Primary Treatment

(2011) Pei-Chen Wu et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Effect of Intravitreal Bevacizumab Based on Optical Coherence Tomography Patterns of Diabetic Macular Edema

(2011) Moosang Kim et al.   OPHTHALMOLOGICA

Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

(2011) Michael J. Elman et al.   OPHTHALMOLOGY

The RESTORE Study

(2011) Paul Mitchell et al.   OPHTHALMOLOGY

CHANGES IN VISUAL ACUITY AND FOVEAL PHOTORECEPTOR INTEGRITY IN EYES WITH CHRONIC CYSTOID MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION

(2011) Yumiko Kurashige et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Systematic review of intravitreal bevacizumab injection for treatment of primary diabetic macular oedema

(2010) Taygan Yilmaz et al.   ACTA OPHTHALMOLOGICA

Muller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage

(2010) J. Wang et al.   DIABETES

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study

(2010) P. Massin et al.   DIABETES CARE

Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

(2010) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Relationship between Optical Coherence Tomography Retinal Parameters and Visual Acuity in Diabetic Macular Edema

(2010) Tarek Alasil et al.   OPHTHALMOLOGY

Diabetic Macular Edema

(2009) Mark Gillies   OPHTHALMOLOGY

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

(2009) Quan Dong Nguyen et al.   OPHTHALMOLOGY

High, Medium, and Low Contrast Visual Acuities in Diabetic Retinal Disease

(2009) Anusha Yasvantrai Sukha et al.   OPTOMETRY AND VISION SCIENCE

Quantitative analysis of central visual field defects in macular edema using three-dimensional computer-automated threshold Amsler grid testing

(2008) Renu V. Jivrajka et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY